Luminai, a San Francisco, CA–based enterprise AI automation platform built for healthcare operations, has raised $38 million in Series B funding, bringing its total capital raised to $60 million.
Investors
The round was led by Peak XV Partners, with participation from Define Ventures and existing investors General Catalyst and Y Combinator.
Peak XV Partners is a venture capital firm focused on investing in startups across India and Southeast Asia. It manages over $10 billion across 16 funds and invests at all stages, from early to late. The firm supports companies in sectors including fintech, SaaS, consumer internet, healthcare, and AI.
Luminai Use of Funds
The company will use the funding to expand product capabilities, grow its engineering and deployment teams, and support increasing demand from enterprise healthcare customers.
About Luminai
Led by CEO Kesava Kirupa Dinakaran, Luminai is an AI-native enterprise automation platform designed specifically for healthcare operations. The company focuses on automating complex administrative workflows that span multiple systems and require contextual understanding. Its platform helps health systems automate complex administrative workflows by leveraging AI to interpret unstructured data, generate actionable insights, and coordinate end-to-end processes across functions such as revenue cycle, compliance, and patient access. Headquartered in San Francisco, California, Luminai combines healthcare-trained AI models, a configurable workflow engine, and human-in-the-loop validation.
Funding Details
Company: Luminai
Raised: $38.0M
Round: Series B
Funding Date: April 2026
Lead Investor: Peak XV Partners
Additional Investors: Define Ventures, General Catalyst, Y Combinator
Company Website: https://www.luminai.com/
Software Category: AI-powered Healthcare Operations / Enterprise Automation
Source: https://www.prnewswire.com/news-releases/luminai-raises-38-million-series-b-to-scale-intelligence-across-health-system-operations-302737804.html